Breast Cancer Research and Treatment

Papers
(The H4-Index of Breast Cancer Research and Treatment is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia130
Area deprivation index and breast cancer outcomes among patients in Western New York107
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer69
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study63
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer54
Long-term dietary intervention influence on physical activity in the Women’s Health Initiative Dietary Modification randomized trial53
Inter-reader agreement of breast magnetic resonance imaging and contrast-enhanced mammography in breast cancer diagnosis: a multi-reader retrospective study50
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy44
Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience37
The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study37
Predicting the likelihood of carrying BRCA1 or BRCA2 pathogenic variants in high-risk Pakistani breast cancer patients36
Integrating SENOMAC and AMAROS: a call for de-escalation34
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study33
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis33
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients32
Prognostic and predictive impact of NOTCH1 in early breast cancer32
Correction: Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy31
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis30
Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health system30
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials28
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast28
Impact of immune-related adverse events on response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: a single-institution retrospective study28
Surveillance mammography after treatment for male breast cancer26
Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000–201626
Temporal patterns of breast cancer incidence, mortality, disability-adjusted life years and risk factors in 12 South American Countries, 1990–2019: an examination using estimates from the global burde25
0.29297399520874